Related Experiment Video

Updated: Jun 17, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Efficient growth inhibition of human osteosarcoma cells using a peptide derived from the MDM-2-binding site of p53

R Ito1, H Kanno, A Takahashi

  • 1Department of Orthopaedic Surgery, Yokohama City University School of Medicine, Yokohama, Japan. wakkyoi5115@hotmail.com

Protein and Peptide Letters
|December 18, 2009
PubMed

Insights

Protein transduction therapy shows promise for osteosarcoma treatment. A p53 peptide effectively inhibited human osteosarcoma cell growth, suggesting a new therapeutic avenue.

Area of Science:

  • Oncology
  • Biotechnology
  • Molecular Therapy

Background:

  • Gene therapy is a common approach for treating osteosarcoma.
  • Protein transduction therapy offers an alternative to gene therapy.
  • The potential of protein transduction therapy for osteosarcoma has not been explored.

Purpose of the Study:

  • To investigate the efficacy of protein transduction therapy for osteosarcoma.
  • To determine if a p53 peptide can inhibit osteosarcoma cell growth.

Main Methods:

  • Utilized protein transduction therapy.
  • Administered a p53 peptide to human osteosarcoma cells in vitro.

Main Results:

  • Demonstrated efficient growth inhibition of human osteosarcoma cells.
  • p53 peptide effectively suppressed tumor cell proliferation.

Conclusions:

  • Protein transduction therapy is a viable therapeutic strategy for osteosarcoma.
  • p53 peptide holds significant potential for novel osteosarcoma treatments.

More Related Videos

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues02:35

Establishment of Patient-Derived Xenograft Mouse Model with Human Osteosarcoma Tissues

Published on: March 22, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...